These results support the potential of IL-6, IL-10, and TNF-α as diagnostic biomarkers and highlight the need for targeted interventions focusing on plaque control and smoking cessation to mitigate the risk of peri-implantitis. The gene discussed is IL6; the disease is Peri-Implantitis.